ArticleResults in chemistry2025
Natural antifibrosis potential of anthocyanin in
Article in Results in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Systematic identification of bacterial neuraminidase inhibitors fromJournal of enzyme inhibition and medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Purple sweet potato (Ipomoea batatas) are known to have bioactive anthocyanin compounds with numerous human therapeutic benefits. Anthocyanins derived from I. batatas can suppress the action of Transforming Growth Factor beta Type II Receptor (TGFβRII) to prevent fibrosis progression. This study aims to examine the molecular features and bioactivity of anthocyanins in I. batatas and determine the interaction of six anthocyanins in I. batatas against TGFβRII through in silico studies. The TGFβRII protein was retrieved from the Protein Data Bank (PDB) database, while the I. batatas anthocyanin was acquired from the PubChem database. Proteins and ligands were docked utilizing the PyRx 0.8 and visualized by Discovery Studio 4.1 software. The in silico study results indicated peonidin-3-glucoside, pelargonidin-3-glucoside, cyanidin 3-o-galactoside, delphinidin 3-glucoside, peonidin 3-galactoside and, cyanidin 3-glucoside were revealed to be efficacious against TGFβRII. Analysis of protein-ligand interactions demonstrates that anthocyanins bind to amino acid residues in the target protein's active site, and these anthocyanins have higher binding energy than the reference drug. I. batatas, one of the traditional medicinal plants containing anthocyanins, has the potential to generate effective therapeutic approaches for the treatment of fibrosis. Additional in-vitro and in-vivo research is highly recommended to comprehend the antifibrosis mechanism adequately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.